Description
CJC-1295 No Dac + Ipamorelin
CJC-1295 No DAC + Ipamorelin is a combination of two research peptides studied for their potential to stimulate growth hormone release. CJC-1295 No DAC, a synthetic analog of growth hormone–releasing hormone (GHRH), is designed to promote short, natural pulses of GH secretion. Ipamorelin, a selective growth hormone secretagogue, acts on ghrelin receptors to further enhance GH release. When researched together, these peptides have shown potential synergistic effects on growth hormone production, cell regeneration, and metabolic processes.
The CJC-1295 No DAC + Ipamorelin Peptide Blend comes in two options:
-
4mg blend: 2mg CJC-1295 No DAC + 2mg Ipamorelin
-
8mg blend: 4mg CJC-1295 No DAC + 4mg Ipamorelin
CJC-1295 no DAC
CJC 1295 no DAC, a widely known Growth Hormone hormone-releasing peptide (GHRP), is a peptide hormone made of amino acids. It was initially designed to boost the synthesis of protein and increase muscle tissue growth, among other benefits.CJC-1295 without DAC is also crucial in assisting in speeding up recovery from injuries, boosting the immune system, cutting down body fat, increasing bone density, and repairing cells of the skin and organs.
| CJC-1295 no DAC | |
| CAS Number | 86168-78-7 |
| Molar Mass | 3357.93 g·mol−1 |
| Chemical Formula | C149H246N44O42S |
| IUPAC Name | 4-[[1-[[1-[[1-[[1-[[5-amino-1-[[1-[[1-[[1-[[6-amino-1-[[1-[[1-[[1-[[5-amino-1-[[1-[[1-[[1-[[1-[[6-amino-1-[[1-[[1-[[5-amino-1-[[1-[[1-[[1-[[1-[(1-amino-5-carbamimidamido-1-oxopentan-2-yl)amino]-3-hydroxy-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-3-carboxy-1-oxopropan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxohexan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxohexan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-[2-[[2-amino-3-(4-hydroxyphenyl)propanoyl]amino]propanoylamino]-4-oxobutanoic acid |
Ipamorelin
Ipamorelin is a growth hormone-releasing peptide (GHRP) that stimulates the release of growth hormones from the anterior pituitary gland. This is a very small gland at the base of the brain responsible for regulating an organism’s endocrine-based functionality. The specificity of ipamorelin makes this compound a very exciting candidate for future clinical research.
| Ipamorelin | |
| CAS number | 170851-70-4 |
| Molar Mass | 711.868 g·mol−1 |
| Chemical Formula | C38H49N9O5 |
| IUPAC Name | (2S)-6-amino-2-[[(2R)-2-[[(2R)-2-[[(2S)-2-[(2-amino-2-methylpropanoyl)amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-3-naphthalen-2-ylpropanoyl]amino]-3-phenylpropanoyl]amino]hexanamide |






Reviews
There are no reviews yet.